Hep C Bulletin: Medication Management
To assist with drug safety in the presence of Hepatitis C infection, patients are urged to take an active role in managing their medications.
Continue reading »To assist with drug safety in the presence of Hepatitis C infection, patients are urged to take an active role in managing their medications.
Continue reading »Treatment naïve patients with Hepatitis C genotype 1 boasted a 100 percent success rate when given Gilead's GS-7977 and Bristol-Myers Squibb's daclatasvir.
Continue reading »Boehringer Ingelheim's all oral Hepatitis C drugs cured 82 percent of patients with the most common type of Hepatitis C in mid-stage trials. In addition, these drugs exhibited the potential to cure people with cirrhosis.
Continue reading »Quercetin is a relative newcomer to the arsenal of nutritional supplements believed to help those with Hepatitis C.
Continue reading »SST (Sho-saiko-to) is made up of seven medicinal plants which, when used together, help to build immunity and stabilize liver health. Learn more about the benefits of SST, and why it was temporarily unavailable until just recently.
Continue reading »A combination of oral drugs - ribavirin and two of Abbott's drugs in development - demonstrated unprecedented Hepatitis C cure rates in a small, mid-stage study.
Continue reading »Using an approach called exhaustive panning, Scripps researchers have advanced the search for a Hepatitis C vaccine by identifying the antibody AR4A.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window